Archives of Pediatric Infectious Diseases

Published by: Kowsar

Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains

Shadi Alimehr 1 , Hamide Shekari Ebrahim Abad 2 , Ahmadreza Shahverdi 3 , Jamal Hashemi 1 , Kamyar Zomorodian 4 , Maryam Moazeni 5 , Sahar Vosoghian 2 and Sassan Rezaie 1 , *
Authors Information
1 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
2 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: April 01, 2015, 3 (2); e21481
  • Published Online: April 15, 2015
  • Article Type: Research Article
  • Received: June 23, 2014
  • Revised: December 3, 2014
  • Accepted: January 28, 2015
  • DOI: 10.5812/pedinfect.21481

To Cite: Alimehr S, Shekari Ebrahim Abad H, Shahverdi A, Hashemi J, Zomorodian K, et al. Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains, Arch Pediatr Infect Dis. 2015 ; 3(2):e21481. doi: 10.5812/pedinfect.21481.

Abstract
Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
4. Results
Footnote
References
  • 1. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20(1): 133-63[DOI][PubMed]
  • 2. Patterson TF. Focus on candidemia. 2007;
  • 3. Nasrollahi A, Pourshamsian K, Mansourkiaee P. Antifungal activity of silver nanoparticles on some of fungi. Int J Nano Dim. 2011; 1(3): 233-9
  • 4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348(16): 1546-54[DOI][PubMed]
  • 5. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003; 37(5): 634-43[DOI][PubMed]
  • 6. Levin MD, den Hollander JG, van der Holt B, Rijnders BJ, van Vliet M, Sonneveld P, et al. Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms. J Antimicrob Chemother. 2007; 60(5): 1104-7[DOI][PubMed]
  • 7. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet. 2000; 38(2): 111-80[DOI][PubMed]
  • 8. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GC, et al. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J Mater Sci Mater Med. 1998; 9(3): 129-34[PubMed]
  • 9. Cho KH, Park JE, Osaka T, Park SG. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochimica Acta. 2005; 51(5): 956-60[DOI]
  • 10. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev. 2003; 27(2-3): 341-53[PubMed]
  • 11. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol. 2005; 5(2): 244-9[PubMed]
  • 12. Lee BU, Yun SH, Ji JH, Bae GN. Inactivation of S. epidermidis, B. subtilis, and E. coli bacteria bioaerosols deposited on a filter utilizing airborne silver nanoparticles. J Microbiol Biotechnol. 2008; 18(1): 176-82[PubMed]
  • 13. Melaiye A, Sun Z, Hindi K, Milsted A, Ely D, Reneker DH, et al. Silver(I)-imidazole cyclophane gem-diol complexes encapsulated by electrospun tecophilic nanofibers: formation of nanosilver particles and antimicrobial activity. J Am Chem Soc. 2005; 127(7): 2285-91[DOI][PubMed]
  • 14. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004; 275(1): 177-82[DOI][PubMed]
  • 15. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res. 2006; 5(4): 916-24[DOI][PubMed]
  • 16. Franke S, Grass G, Nies DH. The product of the ybdE gene of the Escherichia coli chromosome is involved in detoxification of silver ions. Microbiology. 2001; 147: 965-72[PubMed]
  • 17. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007; 3(1): 95-101[DOI][PubMed]
  • 18. Zhao G, Stevens SJ. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals. 1998; 11(1): 27-32[PubMed]
  • 19. Yang W, Shen C, Ji Q, An H, Wang J, Liu Q, et al. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology. 2009; 20(8): 85102[DOI][PubMed]
  • 20. Yamanaka M, Hara K, Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005; 71(11): 7589-93[DOI][PubMed]
  • 21. Park HJ, Kim JY, Kim J, Lee JH, Hahn JS, Gu MB, et al. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res. 2009; 43(4): 1027-32[DOI][PubMed]
  • 22. Benaroudj N, Lee DH, Goldberg AL. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J Biol Chem. 2001; 276(26): 24261-7[DOI][PubMed]
  • 23. Pozniakovsky AI, Knorre DA, Markova OV, Hyman AA, Skulachev VP, Severin FF. Role of mitochondria in the pheromone- and amiodarone-induced programmed death of yeast. J Cell Biol. 2005; 168(2): 257-69[DOI][PubMed]
  • 24. Goa KL, Barradell LB. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs. 1995; 50(4): 658-90[PubMed]
  • 25. Arevalo MP, Arias A, Andreu A, Rodriguez C, Sierra A. Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp. J Chemother. 1994; 6(4): 226-9[PubMed]
  • 26. Van't Wout JW. Fluconazole treatment of candidal infections caused by non-albicans Candida Species. Eur J Clin Microbiol. 1996; 15: 228-42
  • 27. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother. 2004; 54(6): 1019-24[DOI][PubMed]
  • 28. Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev. 2006; 19(2): 435-47[DOI][PubMed]
  • 29. Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, et al. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci. 2008; 8(3): 142-8[PubMed]
  • 30. Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol. 2008; 18(8): 1482-4[PubMed]
  • 31. Kvitek L, Panacek A, Prucek R, Soukupova J, Vanickova M, Kolar M, et al. Antibacterial activity and toxicity of silver – nanosilver versus ionic silver. J Phys: Conference Series. 2011; 304: 12029[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments